Guanosine triphosphate cyclohydrolase 1 promoter deletion causes dopa-responsive dystonia

Mov Disord. 2012 Sep 15;27(11):1451-6. doi: 10.1002/mds.25147. Epub 2012 Sep 13.

Abstract

Background: Autosomal dominant dopa-responsive dystonia (AD-DRD) is caused by a biochemical defect primarily resulting from guanosine triphosphate cyclohydrolase 1 gene (GCH1) mutations. Few families have been reported without mutations in GCH1.

Methods: Genome-wide linkage analysis and positional cloning to identify the genetic defect in a Belgian AD-DRD family was carried out.

Results and conclusion: In this study, we report on the identification and characterization of a novel 24-kb deletion spanning exon 1 and the 5' regulatory region of GCH1 causing a wide spectrum of motor and nonmotor symptoms in a large Belgian AD-DRD family. This large-scale deletion of regulatory sequences leads to decreased GCH1 activity in all carriers, most probably resulting from allelic loss of transcription. We mapped the breakpoints of this deletion to the nucleotide level, allowing the development of a straightforward polymerase chain reaction assay for fast, efficient detection of this large deletion, which will prove valuable for preimplantation genetic diagnosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Belgium
  • Chromosome Mapping
  • Dopamine Agents / therapeutic use
  • Dystonia / drug therapy
  • Dystonia / etiology
  • Dystonia / genetics*
  • Family Health
  • Female
  • GTP Cyclohydrolase / genetics*
  • Genetic Linkage
  • Genome-Wide Association Study
  • Humans
  • Levodopa / therapeutic use
  • Male
  • Middle Aged
  • Promoter Regions, Genetic / genetics*
  • Sequence Deletion / genetics*
  • Young Adult

Substances

  • Dopamine Agents
  • Levodopa
  • GTP Cyclohydrolase